BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27928054)

  • 1. The influence of the 5΄-terminal nucleotide on AgoshRNA activity and biogenesis: importance of the polymerase III transcription initiation site.
    Herrera-Carrillo E; Gao ZL; Harwig A; Heemskerk MT; Berkhout B
    Nucleic Acids Res; 2017 Apr; 45(7):4036-4050. PubMed ID: 27928054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Boosting AgoshRNA activity by optimized 5'-terminal nucleotide selection.
    Gao Z; Berkhout B; Herrera-Carrillo E
    RNA Biol; 2019 Jul; 16(7):890-898. PubMed ID: 30991896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward optimization of AgoshRNA molecules that use a non-canonical RNAi pathway: variations in the top and bottom base pairs.
    Herrera-Carrillo E; Harwig A; Berkhout B
    RNA Biol; 2015; 12(4):447-56. PubMed ID: 25747107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic insights on the Dicer-independent AGO2-mediated processing of AgoshRNAs.
    Liu YP; Karg M; Harwig A; Herrera-Carrillo E; Jongejan A; van Kampen A; Berkhout B
    RNA Biol; 2015; 12(1):92-100. PubMed ID: 25826416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the loop size and nucleotide composition on AgoshRNA biogenesis and activity.
    Herrera-Carrillo E; Harwig A; Berkhout B
    RNA Biol; 2017 Nov; 14(11):1559-1569. PubMed ID: 28569591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of AgoshRNA maturation and loading into Ago2.
    Harwig A; Kruize Z; Yang Z; Restle T; Berkhout B
    PLoS One; 2017; 12(8):e0183269. PubMed ID: 28809941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing of HIV-1 by AgoshRNA molecules.
    Herrera-Carrillo E; Harwig A; Berkhout B
    Gene Ther; 2017 Aug; 24(8):453-461. PubMed ID: 28553929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards Antiviral shRNAs Based on the AgoshRNA Design.
    Liu YP; Karg M; Herrera-Carrillo E; Berkhout B
    PLoS One; 2015; 10(6):e0128618. PubMed ID: 26087209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and Evaluation of AgoshRNAs with 3'-Terminal HDV Ribozymes to Enhance the Silencing Activity.
    Berkhout B; Herrera-Carrillo E
    Methods Mol Biol; 2021; 2167():225-252. PubMed ID: 32712923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing the shRNA characteristics that hinder Dicer recognition and consequently allow Ago-mediated processing and AgoshRNA activity.
    Herrera-Carrillo E; Harwig A; Liu YP; Berkhout B
    RNA; 2014 Sep; 20(9):1410-8. PubMed ID: 25035295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dicer-independent processing of short hairpin RNAs.
    Liu YP; Schopman NC; Berkhout B
    Nucleic Acids Res; 2013 Apr; 41(6):3723-33. PubMed ID: 23376931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of a 3' Terminal Ribozyme on AgoshRNA Biogenesis and Activity.
    Herrera-Carrillo E; Gao Z; Berkhout B
    Mol Ther Nucleic Acids; 2019 Jun; 16():452-462. PubMed ID: 31048184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribozyme-enhanced single-stranded Ago2-processed interfering RNA triggers efficient gene silencing with fewer off-target effects.
    Shang R; Zhang F; Xu B; Xi H; Zhang X; Wang W; Wu L
    Nat Commun; 2015 Oct; 6():8430. PubMed ID: 26455506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep Sequence Analysis of AgoshRNA Processing Reveals 3' A Addition and Trimming.
    Harwig A; Herrera-Carrillo E; Jongejan A; van Kampen AH; Berkhout B
    Mol Ther Nucleic Acids; 2015 Jul; 4(7):e247. PubMed ID: 26172504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in silencing of mismatched targets by sliced versus diced siRNAs.
    Sun G; Wang J; Huang Y; Yuan CW; Zhang K; Hu S; Chen L; Lin RJ; Yen Y; Riggs AD
    Nucleic Acids Res; 2018 Jul; 46(13):6806-6822. PubMed ID: 29718312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure, stability and in vitro RNAi activity of oligoribonucleotides containing the ribo-difluorotoluyl nucleotide: insights into substrate requirements by the human RISC Ago2 enzyme.
    Li F; Pallan PS; Maier MA; Rajeev KG; Mathieu SL; Kreutz C; Fan Y; Sanghvi J; Micura R; Rozners E; Manoharan M; Egli M
    Nucleic Acids Res; 2007; 35(19):6424-38. PubMed ID: 17881374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of RNAi Responses by Short Left-Handed Hairpin RNAi Triggers.
    Hagopian JC; Hamil AS; van den Berg A; Meade BR; Eguchi A; Palm-Apergi C; Dowdy SF
    Nucleic Acid Ther; 2017 Oct; 27(5):260-271. PubMed ID: 28933656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D-Isonucleotide (isoNA) incorporation around cleavage site of passenger strand promotes the vibration of Ago2-PAZ domain and enhances in vitro potency of siRNA.
    Huang Y; Tian M; Zhang Y; Sheng G; Chen Z; Ma Y; Chen Y; Peng Y; Zhao YL; Wang Y; Zhang L; Yang Z
    Org Biomol Chem; 2015 Nov; 13(44):10825-33. PubMed ID: 26313718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Right- and left-loop short shRNAs have distinct and unusual mechanisms of gene silencing.
    Dallas A; Ilves H; Ge Q; Kumar P; Shorenstein J; Kazakov SA; Cuellar TL; McManus MT; Behlke MA; Johnston BH
    Nucleic Acids Res; 2012 Oct; 40(18):9255-71. PubMed ID: 22810205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Novel Small Hairpin RNAs That do not Require Processing by Dicer or AGO2.
    Ohno S; Itano K; Harada Y; Asada K; Oikawa K; Kashiwazako M; Okuyama H; Kumagai K; Takanashi M; Sudo K; Ikeda N; Kuroda M
    Mol Ther; 2016 Aug; 24(7):1278-89. PubMed ID: 27109632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.